Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,215,892
+$468,756 QoQ
Shares Held
59,551
+8.1% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#99
of 252 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. CLDX ranks #75 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in CLDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,215,892 | 59,551 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,747,136 | 55,080 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,700,187 | 62,599 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,800,007 | 69,579 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,448,715 | 71,190 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,164,158 | 64,141 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,625,719 | 64,334 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,140,723 | 62,981 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $2,158,718 | 58,328 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,367,359 | 56,406 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $2,062,795 | 52,012 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $1,124,026 | 40,844 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,254,425 | 36,971 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $677,178 | 18,821 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $767,271 | 17,215 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $473,793 | 16,855 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $434,702 | 16,124 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $571,390 | 16,776 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $638,216 | 16,517 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $905,411 | 16,770 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $204,083 | 6,103 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $35,040 | 1,701 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $29,801 | 1,701 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||